Detalles de la búsqueda
1.
CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece.
Clinicoecon Outcomes Res
; 15: 97-109, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36825076
2.
Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece.
Clin Drug Investig
; 41(4): 371-380, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33687695
3.
Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in Greece.
Hellenic J Cardiol
; 62(3): 234-240, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683128
4.
The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.
Ther Adv Respir Dis
; 14: 1753466620926802, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519591
5.
Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.
Clin Drug Investig
; 38(5): 417-426, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29349708
Resultados
1 -
5
de 5
1
Próxima >
>>